Fidelity Investments’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3K | Buy |
|
|||||
|
2025
Q1 | $1.97K | Sell |
|
|||||
|
2024
Q4 | $279K | Buy |
|
|||||
|
2024
Q3 | $307K | Buy |
|
|||||
|
2024
Q2 | $254K | Buy |
|
|||||
|
2024
Q1 | $413K | Buy |
|
|||||
|
2023
Q4 | $232K | Buy |
|
|||||
|
2023
Q3 | $357K | Buy |
|
|||||
|
2023
Q2 | $476K | Buy |
|
|||||
|
2023
Q1 | $447K | Buy |
|
|||||
|
2022
Q4 | $377K | Sell |
|
|||||
|
2022
Q3 | $612K | Sell |
|
|||||
|
2022
Q2 | $507K | Sell |
|
|||||
|
2022
Q1 | $840K | Buy |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $833K | Sell |
|
|||||
|
2020
Q4 | $2.49M | Sell |
|
|||||
|
2020
Q3 | $2.58M | Sell |
|
|||||
|
2020
Q2 | $12.8M | Sell |
|
|||||
|
2020
Q1 | $14.8M | Buy |
|
|||||
|
2019
Q4 | $12.1M | Sell |
|
|||||
|
2019
Q3 | $7.45M | Sell |
|
|||||
|
2019
Q2 | $6.28M | Sell |
|
|||||
|
2019
Q1 | $8.96M | Sell |
|
|||||
|
2018
Q4 | $17.6M | Buy |
|
|||||
|
2018
Q3 | $21.1M | Sell |
|
|||||
|
2018
Q2 | $26.2M | Sell |
|
|||||
|
2018
Q1 | $40.7M | Sell |
|
|||||
|
2017
Q4 | $38.2M | Sell |
|
|||||
|
2017
Q3 | $44M | Sell |
|
|||||
|
2017
Q2 | $39.1M | Hold |
|
|||||
|
2017
Q1 | $55.5M | Sell |
|
|||||
|
2016
Q4 | $44.5M | Sell |
|
|||||
|
2016
Q3 | $52.2M | Hold |
|
|||||
|
2016
Q2 | $36M | Hold |
|
|||||
|
2016
Q1 | $47.8M | Hold |
|
|||||
|
2015
Q4 | $71M | Buy |
|
|||||
|
2015
Q3 | $56.4M | Buy |
|
|||||
|
2015
Q2 | $146M | Buy |
|
|||||
|
2015
Q1 | $159M | Buy |
|
|||||
|
2014
Q4 | $184M | Buy |
|
|||||
|
2014
Q3 | $142M | Buy |
|
|||||
|
2014
Q2 | $159M | Buy |
|
|||||
|
2014
Q1 | $72.5M | Hold |
|
|||||
|
2013
Q4 | $53.8M | Buy |
|